Pneumonia is a lung infection caused by bacteria, viruses or fungi, primarily affecting the small sir sacs known as alveoli. The most common bacterial type that causes pneumonia is Streptococcus pneumoniae. The symptoms for pneumonia include, fever, chills, cough, shortness of breath and fatigue. To detect whether, a person has pneumonia are blood tests, chest X-ray, pulse oximetry, and Sputum test. Further, if the patients is older than age 65, additional tests are included for detection of pneumonia. For instance, CT scan, Pleural fluid culture.
The blood tests are used to confirm an infection and to try to identify the type of organism causing the infection, but however precise identification is not always possible through the blood tests. Further, the chest X-ray also helps the doctor to diagnose pneumonia and determine the extent and location of the infection. The chest X-ray can also detect the kind of germ is causing pneumonia. The pulse oximetry test is performed to measure the oxygen level in the blood, as Pneumonia can prevents lungs from moving enough oxygen into the bloodstream. Besides all these test the sputum test is used to analyses or pinpoint the cause of the infection with the sample of fluid from lungs, which is taken after deep cough.
Furthermore, if the pneumonia isn’t clearing as quickly as expected the doctors recommend a chest CT scan to obtain a more detailed image of the lungs. Moreover, if the patients shows serious symptoms or health conditions pleural fluid culture test is carried out where a fluid sample is taken by putting a needle between the ribs from the pleural area to analyze the type of infection.
Pneumonia Testing Market Dynamics
The recent advancements in pneumonia testing systems, such as the development of enhanced nucleic acid detection tests and advancement in POC tests is the major factor that contributes toward the growth of the pneumonia testing market size. As POC tests offers multiple benefits offered such as, ease of use, and rapid results. For instance, The urinary antigen is an extremely-effective rapid test that allows targeted therapy foe legionnaire at the point-of-care itself.
Further, increasing adoption of molecular diagnostic test in the developing economy is anticipated to provide lucrative opportunities to the pneumonia testing market. Due to increased application of biomarkers in molecular diagnostic, due to advantages of biomarkers such as aiding in early detection of specific diseases, supports the molecular diagnostics test for pneumonia testing market.
Initially, in the traditional method, cultures are used to detect pneumonia causative organisms. This is a time-consuming process with a higher error rate when compared to rapid diagnostics. In a few cases such as legionella, culture identification is not readily available and this increases the mortality rate of pneumonia cases caused by it.
Pneumonia Testing Market - Regional Insights
North America accounted for the largest share in the pneumonia testing market, followed by Europe market in 2016. This is attributed to growing popularity for POC tests within the healthcare sector. Further, the ongoing research and development activities are also on rise for the development of more advanced PCR-based technologies, which could be used for faster results.
Further, pneumonia testing market in accounts second largest share in Europe region, primarily because of their robust, well-developed healthcare infrastructure and a greater awareness of a geriatric population likely to develop such health issues.
Furthermore, several pharmaceutical and biotechnological companies are focusing on expanding in Asia Pacific region, to maximize on their R&D efforts as the Asia Pacific region provides better access to patients for clinical trials, with lower cost operational efficiencies. Increasing government investment in research and development is also expected to foster growth of Pneumonia Testing in Asia Pacific region.
Pneumonia Testing Market - Competitive Analysis
Major players are focused on collaborations and mergers, to enter the pneumonia testing market. For instance, in April 2017, Abbott acquired Alere, which dominated POC testing for pneumonia testing market with its BinaxNOW Streptococcus pneumoniae antigen card for bacterial pneumonia and BinaxNOW RSV Card for viral pneumonia.
Key players operating in the market are Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.
Pneumonia Testing Market - Taxonomy:
By Product Type:
By End User
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.